Franklin Resources Inc Sio Gene Therapies Inc. Transaction History

Franklin Resources Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.25 - $0.73 $6,638 - $19,382	-26,552 Reduced 32.33%	55,570 $20,000
Q4 2021 Feb 11, 2022	SELL	$1.29 - $2.36 $487 - $892	-378 Reduced 0.46%	82,122 $106,000
Q3 2021 Nov 12, 2021	BUY	$1.81 - $2.7 $149,325 - $222,750	82,500 New	82,500 $179,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.